DD202029A5 - Verfahren zur herstellung von neuen substituierten ethern von 5-hydroxy-5h-(1) benzopyrano (4,3-d) pyrimidinen - Google Patents

Verfahren zur herstellung von neuen substituierten ethern von 5-hydroxy-5h-(1) benzopyrano (4,3-d) pyrimidinen Download PDF

Info

Publication number
DD202029A5
DD202029A5 DD81234079A DD23407981A DD202029A5 DD 202029 A5 DD202029 A5 DD 202029A5 DD 81234079 A DD81234079 A DD 81234079A DD 23407981 A DD23407981 A DD 23407981A DD 202029 A5 DD202029 A5 DD 202029A5
Authority
DD
German Democratic Republic
Prior art keywords
radical
lower alkyl
phenyl
compound
formula
Prior art date
Application number
DD81234079A
Other languages
German (de)
English (en)
Inventor
Haas
Sele
Jaeggi
Eichenberger
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD202029A5 publication Critical patent/DD202029A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
DD81234079A 1980-10-17 1981-10-14 Verfahren zur herstellung von neuen substituierten ethern von 5-hydroxy-5h-(1) benzopyrano (4,3-d) pyrimidinen DD202029A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH777480 1980-10-17

Publications (1)

Publication Number Publication Date
DD202029A5 true DD202029A5 (de) 1983-08-24

Family

ID=4330256

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81234079A DD202029A5 (de) 1980-10-17 1981-10-14 Verfahren zur herstellung von neuen substituierten ethern von 5-hydroxy-5h-(1) benzopyrano (4,3-d) pyrimidinen

Country Status (13)

Country Link
EP (1) EP0051177A3 (enExample)
JP (1) JPS57118517A (enExample)
AU (1) AU7654181A (enExample)
DD (1) DD202029A5 (enExample)
DK (1) DK459081A (enExample)
ES (1) ES8301993A1 (enExample)
FI (1) FI813189L (enExample)
GB (1) GB2086382A (enExample)
GR (1) GR75076B (enExample)
IL (1) IL64055A0 (enExample)
NO (1) NO813495L (enExample)
PT (1) PT73833B (enExample)
ZA (1) ZA817129B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993014080A1 (en) * 1992-01-15 1993-07-22 E.I. Du Pont De Nemours And Company Bridged heterocyclic fungicides

Also Published As

Publication number Publication date
JPS57118517A (en) 1982-07-23
EP0051177A2 (de) 1982-05-12
DK459081A (da) 1982-04-18
GR75076B (enExample) 1984-07-13
FI813189A7 (fi) 1982-04-18
GB2086382A (en) 1982-05-12
ES506271A0 (es) 1982-12-16
ES8301993A1 (es) 1982-12-16
PT73833B (en) 1983-11-07
ZA817129B (en) 1982-09-29
FI813189L (fi) 1982-04-18
AU7654181A (en) 1982-04-22
PT73833A (en) 1981-11-01
IL64055A0 (en) 1982-01-31
NO813495L (no) 1982-04-19
EP0051177A3 (de) 1982-06-23

Similar Documents

Publication Publication Date Title
DE68913831T2 (de) Kondensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69916578T2 (de) Pyrazolotriazine als crf-antagonisten
DE2818676A1 (de) Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0058341B1 (de) Azepinderivate, ihre Herstellung und diese enthaltende Arzneimittel
JPS6136282A (ja) 窒素を含む複素環式化合物からなる医薬品とその製造方法
DE2920250C2 (enExample)
KR890001425B1 (ko) 피리도 [2,3-d] 피리미딘-5-온류 및 그의 제법
EP0255028A2 (de) Neue 1,4-Benzodiazepine, ihre Herstellung und Verwendung als PAF Antagonisten
DE69127010T2 (de) Selektive Adenosinreceptoren
DE2804519C2 (enExample)
DE2405395A1 (de) Verfahren zur herstellung von neuen azinen und ihren tautomeren
NZ203519A (en) 2(1h)-pyridinone derivatives and pharmaceutical compositions
DE3204403A1 (de) Neue pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0094080B1 (de) Pyrido(2,1-b)chinazolinderivate
EP0163842A1 (de) Tricyclische Imidazolderivate
DE2229845A1 (de) Tnazolothienodiazepinverbindung und Verfahren zu deren Herstellung
DD202029A5 (de) Verfahren zur herstellung von neuen substituierten ethern von 5-hydroxy-5h-(1) benzopyrano (4,3-d) pyrimidinen
DE3785987T2 (de) Imidazol-derivate und deren salze, verfahren zu deren herstellung, deren anwendung als arzneimittel und deren zusammensetzungen.
DE2233682A1 (de) 2- eckige klammer auf 3-(subst. aminomethyl)-4-h-1,2,4-triazol-4-yl eckige klammer zu -benzophenone, ein verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
US5114944A (en) 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects
DE69719071T2 (de) Phenanthridiniumderivate
EP0054839A2 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2259471A1 (de) Neue 6-aza-3h-1,4-benzodiazepine
DE2441206A1 (de) 1- oder 2-mono- und -dialkylsubstituierte thienobenzopyrane
DD201594A5 (de) Verfahren zur herstellung von neuen polyazaheterocyclischen verbindungen